Table 1 Clinical and anatomic characteristics by access site
Characteristics | FV/FA (n = 34) | CA (n = 27) | P |
|---|---|---|---|
Sex, n (%) | |||
Male | 16 (47) | 11 (40) | 0.408 |
Female | 18 (53) | 17 (60) | |
Age at PDA stenting, days (median: min–max) | 63: 7–485 | 42:11–1490 | 0.649 |
Weight at procedure, Kgs (mean: min–max) | 4.5: 3–8.3 | 3.9: 2.1–7.4 | 0.1 |
Primary Diagnostic Category, n (%) | |||
PA–IVS | 19 (56) | 5 (15) | 0.006* |
PA with VSD/CAVSD | 3 (9) | 21 (62) | < 0.001* |
TGA–IVS | 5 (15) | 0 (0) | 0.038 |
TGA with restrictive VSD | 3 (9) | 0 (0) | 0.166 |
DORV with PS | 2 (6) | 1 (3) | 0.693 |
PDA as single source of PBF, n (%) | 22 (65) | 24 (70) | 0.17 |
Krichenko PDA Classification, n (%) | |||
Type A | 24 (70) | 14 (41) | 0.355 |
Type B | 1 (3) | 2 (7) | 0.423 |
Type C | 12 (11) | 2 (7) | 0.453 |
Type D | 2 (6) | 5 (15) | 0.129 |
Type E | 3 (9) | 2 (7) | 0.61 |
Significant Branch PA stenosis | 3 (9) | 4 (12) | 0.241 |
PGE-1 usage pre-intervention, n (%) | 3 (16) | 10 (37) | 0.002* |
Inotropic administration pre-intervention, n (%) | 10 (29) | 7 (26) | 0.079 |
Other medical conditions, n (%) | |||
Sepsis | 2 (6) | 2 (7) | 0.089 |
Anemia preprocedural | 4 (12) | 2 (7) | 0.633 |
Others | 0 (0) | 2 (7) | 0.599 |
Location of the PDA, n (%) | |||
Underside Aortic Arch | 3 (9) | 25 (93) | < 0.001* |
Descending Aorta | 29 (85) | 2 (7) | < 0.001* |
Aborted left/right aortic arch | 2 (6) | 0 (0) | 0.29 |
Other interventions, n (%) | |||
BAS | 16 (47) | 2 (7) | 0 |
IAS stenting | 1 (3) | 0 (0) | 0.557 |
TPM | 1 (3) | 0 (0) | 0.557 |
MAPCAs embolization | 0 (0) | 2 (7) | 0.192 |